Larvol Delta - Cancer-Targeted-Technology-Receives-Fast-Track-24M-Grant-to-Develop-an-Innovative-PSMATargeted-Small-Molecule-Drug-Conjugate-for-Prostate-Cancer

CTT-2274 - Cancer Targeted Tech

https://www.businesswire.com/news/home/20241117728594/en/Cancer-Targeted-Technology-Receives-Fast-Track-2.4M-Grant-to-Develop-an-Innovative-PSMA-Targeted-Small-Molecule-Drug-Conjugate-for-Prostate-Cancer

Nov 18, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next